Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects

BACKGROUND: In type 2 diabetes mellitus therapy, fixed-dose combination (FDC) can offer not only benefits in glucose control via the combined use of agents, but also increase patient compliance. The aim of this study was to assess the pharmacokinetic equivalence of the high dose of the FDC tablet (g...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yong-Soon, Lee, Shi Hyang, Lim, Hyeong-Seok, Bae, Kyun-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170670/
https://www.ncbi.nlm.nih.gov/pubmed/30288156
http://dx.doi.org/10.3346/jkms.2018.33.e258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170670/
https://www.ncbi.nlm.nih.gov/pubmed/30288156
http://dx.doi.org/10.3346/jkms.2018.33.e258

Ejemplares similares